NCT01353690View on ClinicalTrials.gov

Autologous Cell Therapy for Ischemic Heart Failure

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 5, 2011

Primary Completion Date

December 12, 2012

Study Completion Date

June 30, 2014

Conditions
Ischemic Heart Disease
Interventions
BIOLOGICAL

AMDC

Cell Treatment

Trial Locations (2)

T6G 2B7

University of Alberta and Mazankowski Alberta Heart Institute, Edmonton

H1T 1C8

Montreal Heart Institute, Montreal

Sponsors

Lead Sponsor

Cook MyoSite
All Listed Sponsors
lead

Cook MyoSite

INDUSTRY